MTN-017 Trial Launch Webinar
Be the Generation Bridge and International Rectal Microbicide Advocates (IRMA) hosted a webinar to mark the launch of MTN-017, the first-ever phase II safety study of a rectal microbicide. Ross D. Cranston, MD, of the University of Pittsburgh School of Medicine and co-leader of MTN-017, presented on the trial details, followed by Jim Pickett of IRMA who presented on the community engagement activities undertaken in support of the trial.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!